UB Paderborn / Katalog / Suche / in CDI

Update on systemic therapies of metastatic renal cell carcinoma

World journal of urology, 2010-06, Vol.28 (3), p.303-309

2010

Link zum Volltext

Verfügbarkeit prüfen

Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study

ESMO open, 2021-10, Vol.6 (5), p.100241-100241, Article 100241

2021

Link zum Volltext

Verfügbarkeit prüfen

Electrical manipulation of glycan-phosphatidyl inositol-tethered proteins in planar supported bilayers

Biophysical journal, 1996-11, Vol.71 (5), p.2716-2723

1996

Link zum Volltext

Verfügbarkeit prüfen

A Receptor/Cytoskeletal Movement Triggered by Costimulation During T Cell Activation

Science (American Association for the Advancement of Science), 1998-12, Vol.282 (5397), p.2266-2269

1998

Link zum Volltext

Verfügbarkeit prüfen

Differential Clustering of CD4 and CD3ζ during T Cell Recognition

Science (American Association for the Advancement of Science), 2000-08, Vol.289 (5483), p.1349-1352

2000

Link zum Volltext

Verfügbarkeit prüfen

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder

European journal of surgical oncology, 2012-07, Vol.38 (7), p.637-642

2012

Link zum Volltext

Verfügbarkeit prüfen

Operative Therapie der benignen Prostatahyperplasie – Versorgungsrealität und Outcome

Journal für Urologie und Urogynäkologie, 2019-06, Vol.26 (2), p.56-65

2019

Link zum Volltext

Verfügbarkeit prüfen

Visualizing the Dynamics of T Cell Activation: Intracellular Adhesion Molecule 1 Migrates Rapidly to the T Cell/B Cell Interface and Acts to Sustain Calcium Levels

Proceedings of the National Academy of Sciences - PNAS, 1998-05, Vol.95 (11), p.6302-6307

1998

Link zum Volltext

Verfügbarkeit prüfen

614P Circulating tumor cell (CTC) morphologic sub-types present prior to treatment in the CARD trial identify therapy resistance

Annals of oncology, 2021-09, Vol.32, p.S653-S654

2021

Link zum Volltext

Verfügbarkeit prüfen

Correctly Folded T-cell Receptor Fragments in the Periplasm of Escherichia coli: Influence of Folding Catalysts

Journal of molecular biology, 1994-10, Vol.242 (5), p.655-669

1994

Link zum Volltext

Verfügbarkeit prüfen

Efficient production of heat-labile enterotoxin mutant proteins by overexpression of dsbA in a degP-deficient Escherichia coli strain

Archives of microbiology, 1997-05, Vol.167 (5), p.280-283

1997

Link zum Volltext

Verfügbarkeit prüfen

CARD: Randomized, open-label study of cabazitaxel (CBZ) vs abiraterone (ABI) or enzalutamide (ENZ) in metastatic castration-resistant prostate cancer (mCRPC)

Annals of oncology, 2019-10, Vol.30, p.v882-v883

2019

Link zum Volltext

Verfügbarkeit prüfen

LBA13 - CARD: Randomized, open-label study of cabazitaxel (CBZ) vs abiraterone (ABI) or enzalutamide (ENZ) in metastatic castration-resistant prostate cancer (mCRPC)

Annals of oncology, 2019-10, Vol.30, p.v882-v883

2019

Link zum Volltext

Verfügbarkeit prüfen

Expression of Endothelin-A-Receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer

British journal of cancer, 2004-08, Vol.91 (3), p.434-440

2004

Link zum Volltext

Verfügbarkeit prüfen

CARD: A randomized phase 4 trial comparing cabazitaxel and an androgen receptor (AR)-targeted agent in men with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and an alternative AR-targeted agent

Annals of oncology, 2016-10, Vol.27, p.vi262-vi262

2016

Link zum Volltext

Verfügbarkeit prüfen

The Vav Exchange Factor Is an Essential Regulator in Actin-Dependent Receptor Translocation to the Lymphocyte-Antigen-Presenting Cell Interface

Proceedings of the National Academy of Sciences - PNAS, 2000-08, Vol.97 (18), p.10150-10155

2000

Link zum Volltext

Verfügbarkeit prüfen

Protein folding in the periplasm of Escherichia coli

Molecular microbiology, 1994-06, Vol.12 (5), p.685-692

1994

Link zum Volltext

Verfügbarkeit prüfen

Cyclooxygenase-2 Expression in Bladder Cancer: Correlation with Poor Outcome after Chemotherapy

European urology, 2004, Vol.45 (1), p.46-52

2004

Link zum Volltext

Verfügbarkeit prüfen

Kinetics and extent of T cell activation as measured with the calcium signal

The Journal of experimental medicine, 1997-05, Vol.185 (10), p.1815-1825

1997

Link zum Volltext

Verfügbarkeit prüfen

Perspektiven für die Therapie des kastrationsrefraktären Prostatakarzinoms: Aktuelle Empfehlungen der neuen S3-Leitlinie und neue Entwicklungen

Best practice onkologie, 2010, Vol.5 (6), p.24-29

2010

Link zum Volltext

Verfügbarkeit prüfen

Endothelin-1-, Endothelin-A-, and Endothelin-B-Receptor Expression Is Correlated with Vascular Endothelial Growth Factor Expression and Angiogenesis in Breast Cancer

Clinical cancer research, 2004-04, Vol.10 (7), p.2393-2400

2004

Link zum Volltext

Verfügbarkeit prüfen

1087 Surgical treatment of benign prostatic obstruction – consecutive real life data of 2648 patients

European urology supplements : official journal of the European Association of Urology, 2016-03, Vol.15 (3), p.e1087-e1087a

2016

Link zum Volltext

Verfügbarkeit prüfen

AUO - Nicht interventionelle Studie zur Therapie von Neutropenien

Aktuelle Urologie, 2016-05, Vol.47 (3), p.189

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Update on systemic therapies of metastatic renal cell carcinoma

Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study

Electrical manipulation of glycan-phosphatidyl inositol-tethered proteins in planar supported bilayers

A Receptor/Cytoskeletal Movement Triggered by Costimulation During T Cell Activation

Differential Clustering of CD4 and CD3ζ during T Cell Recognition

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder

Operative Therapie der benignen Prostatahyperplasie – Versorgungsrealität und Outcome

Visualizing the Dynamics of T Cell Activation: Intracellular Adhesion Molecule 1 Migrates Rapidly to the T Cell/B Cell Interface and Acts to Sustain Calcium Levels

To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic

614P Circulating tumor cell (CTC) morphologic sub-types present prior to treatment in the CARD trial identify therapy resistance

629P Neutrophil-lymphocyte ratio (NLR) as a prognostic and predictive biomarker in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with cabazitaxel (CBZ) vs abiraterone or enzalutamide in the CARD study

Correctly Folded T-cell Receptor Fragments in the Periplasm of Escherichia coli: Influence of Folding Catalysts

Efficient production of heat-labile enterotoxin mutant proteins by overexpression of dsbA in a degP-deficient Escherichia coli strain

CARD: Randomized, open-label study of cabazitaxel (CBZ) vs abiraterone (ABI) or enzalutamide (ENZ) in metastatic castration-resistant prostate cancer (mCRPC)

LBA13 - CARD: Randomized, open-label study of cabazitaxel (CBZ) vs abiraterone (ABI) or enzalutamide (ENZ) in metastatic castration-resistant prostate cancer (mCRPC)

Expression of Endothelin-A-Receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer

CARD: A randomized phase 4 trial comparing cabazitaxel and an androgen receptor (AR)-targeted agent in men with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and an alternative AR-targeted agent

The Vav Exchange Factor Is an Essential Regulator in Actin-Dependent Receptor Translocation to the Lymphocyte-Antigen-Presenting Cell Interface

Protein folding in the periplasm of Escherichia coli

Cyclooxygenase-2 Expression in Bladder Cancer: Correlation with Poor Outcome after Chemotherapy

Kinetics and extent of T cell activation as measured with the calcium signal

Perspektiven für die Therapie des kastrationsrefraktären Prostatakarzinoms: Aktuelle Empfehlungen der neuen S3-Leitlinie und neue Entwicklungen

Endothelin-1-, Endothelin-A-, and Endothelin-B-Receptor Expression Is Correlated with Vascular Endothelial Growth Factor Expression and Angiogenesis in Breast Cancer

1087 Surgical treatment of benign prostatic obstruction – consecutive real life data of 2648 patients

AUO - Nicht interventionelle Studie zur Therapie von Neutropenien

Suchergebnisse filtern